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Neurons in the nascent dorsal root ganglia are born and differentiate in a complex cellular milieu composed of postmitotic neurons, and
mitotically active glial and neural progenitor cells. Neurotrophic factors such as NT-3 are critically important for promoting the survival of
postmitotic neurons in the DRG. However, the factors that regulate earlier events in the development of the DRG such as the mitogenesis of DRG
progenitor cells and the differentiation of neurons are less defined. Here we demonstrate that both NT-3 and CNTF induce distinct dose-dependent
responses on cells in the immature DRG: at low concentrations, they induce the proliferation of progenitor cells while at higher concentrations
they promote neuronal differentiation. Furthermore, the mitogenic response is indirect; that is, NT-3 and CNTF first bind to nascent neurons in the
DRG—which then stimulates those neurons to release mitogenic factors including neuregulin. Blockade of this endogenous neuregulin activity
completely blocks the CNTF-induced proliferation and reduces about half of the NT-3-mediated proliferation. Thus, the genesis and differentiation
of neurons and glia in the DRG are dependent upon reciprocal interactions among nascent neurons, glia, and mitotically active progenitor cells.
© 2006 Elsevier Inc. All rights reserved.Keywords: Neurotrophin; NT-3; CNTF; Progenitor; Sensory neuron; Dorsal root ganglion; ChickIntroduction
The dorsal root ganglia (DRG) are composed of a
functionally and molecularly heterogeneous population of
sensory neurons and two distinct classes of glia (Scott,
1992). The cells of the DRG derive from migrating neural
crest cells that arrest and aggregate laterally to the neural
tube (Weston, 1963; LeDouarin, 1982; Lallier and Bronner-
Fraser, 1988). As sensory neurons differentiate, they
innervate central and peripheral targets and undergo a well
characterized process of target regulated programmed cell⁎ Corresponding author. Fax: +1 406 994 7077.
E-mail address: lefcort@montana.edu (F. Lefcort).
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doi:10.1016/j.ydbio.2006.05.007death. However, the intermediate events that occur subse-
quent to the formation of the DRG primordial, yet prior to
target innervation, remain poorly understood. Using electron
microscopy, Pannese identified a population of mitotically
active progenitor cells in the immature chick DRG that were
most prominent between embryonic days 4 and 6 (Pannese,
1974). Elegant back-transplantation studies in ovo have
demonstrated the transient existence of a population of
potential autonomic precursor cells within the DRG at the
same time period (Schweizer et al., 1983). The complete
molecular characterization of progenitor cells within the
DRG has yet to be accomplished nor have the extracellular
signals that regulate their behavior been identified. When
immature DRG are dissociated and the clonal progeny of
individual mitotically active cells characterized in vitro, both
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the presence of both multipotent and fate restricted
progenitor (and precursor) cells (Duff et al., 1991; Hagedorn
et al., 1999, 2000; Henion and Weston, 1997; Luo et al.,
2003). From such studies, extracellular factors have been
identified that can regulate the differentiation of discrete cell
types, either selectively or instructively, revealing the
developmental potential of progenitor cells resident within
the DRG (reviewed in Sieber-Blum, 2000; Sommer, 2001).
Although the peak of neurogenesis temporally precedes that
of gliogenesis (Carr and Simpson, 1978), neuronal differenti-
ation temporally overlaps with cellular proliferative events
within the developing DRG. In fact, dividing progenitor cells
are often observed adjacent to differentiated neurons, even next
to neurons undergoing programmed cell death (Rifkin et al.,
2000). Furthermore, there is a rich literature demonstrating the
multiple influences neurons and Schwann cells exert upon each
other to ultimately sculpt their development and differentiation
(Wood and Bunge, 1975; Bhattacharyya et al., 1991; Dong et
al., 1995; Meyer and Birchmeier, 1995; Davies, 1998; Jessen
and Mirsky, 1999; Chen et al., 2003; Esper and Loeb, 2004). In
the immature DRG, during the peak period of neurogenesis, the
two major cell types are postmitotic neurons and mitotically
active progenitor cells (Pannese, 1974; Carr and Simpson,
1978). Thus, cells in the developing DRG are dividing and
differentiating simultaneously in a rich milieu of extracellular
signals, secreted and membrane bound on adjacent cells. These
intercellular interactions and the cell-secreted factors directly
and/or indirectly regulate such diverse biological activities as
cell proliferation, survival, and differentiation (Nielsen et al.,
2004). The mechanisms by which mitotically active cells
integrate such a complexity of signals and yet adopt one
particular biological response remain a major question in
biology (Schlessinger, 2000; Sauvageot et al., 2005). The DRG
provides a useful model system in which to address this
question. To this end, the environmental signals that regulate the
activity of cycling progenitor cells must be identified, while
maintaining the physical relationship between postmitotic
neurons and mitotically active DRG progenitor cells.
Much is known about the extracellular signals that regulate
the survival of postmitotic neurons within the DRG. For
example, members of the neurotrophin family of growth factors
and their receptors, the trk family of receptor tyrosine kinases,
are critically important for maintaining the survival of distinct
subsets of DRG neurons during and following target innerva-
tion (Lindsay, 1996; reviewed in Huang and Reichardt, 2001).
Neuropoietic cytokines including CNTF have also been shown
to support the survival of postmitotic sensory neurons within the
DRG (Barbin et al., 1984; Murphy et al., 1994; Memberg et al.,
1995; Von Holst et al., 1997). Interestingly, the chick
homologue of the CNTF receptor alpha (CNTFRα), GPA
receptor alpha (GPARα; Heller et al., 1995), is highly expressed
in the immature chick DRG prior to the period of programmed
cell death, although its function during this early time period is
unknown (Heller et al., 1995; Von Holst et al., 1997). CNTF
activates the tripartite CNTF receptor which in addition to
CNTFrα is composed of the ubiquitously expressed gp130 andLIFRβ; the ligand-binding component of the complex is
CNTFRα, which upon binding ligand, complexes with gp130
and LIFRβ (Stahl and Yancopoulos, 1994). In addition to
CNTF, another ligand for CNTFRα is the composite cytokine
Cardiotrophin-like cytokine/Cytokine-like Factor-1, which acts
as a trophic factor for chick motor neurons (CLC/CLF; Elson et
al., 2000; Plun-Favreau et al., 2001; Forger et al., 2003). Chick
CNTF/GPA is expressed during development, and secreted via
a novel pathway, and has been demonstrated to be necessary for
the survival of chick ciliary neurons (Reiness et al., 2001; Finn
et al., 1998).
In contrast, the growth factors that regulate the behavior
of mitotically active DRG progenitors in the immature DRG
remain incompletely characterized. Several studies have
implicated a role for neurotrophin-3 (NT-3) in sensory
neuron development in vitro (Wright et al., 1992; Pinco et
al., 1993; Henion et al., 1995; Kalcheim et al., 1992;
Memberg et al., 1995). NT-3 is expressed in both the neural
tube and the adjacent mesenchyme during the peak periods
of neurogenesis in the DRG (Pinco et al., 1993; Farinas et
al., 1996). However, identifying NT-3′s activities in the
immature DRG in vivo has proven to be complex. For
example, antibody blockade of either NT-3 or its receptor,
trkC, in ovo, over a time period that included target
innervation, resulted in the loss of about 40–50% of neurons
in the DRG (Gaese et al., 1994; Lefcort et al., 1996).
Interestingly, when applied and analyzed prior to the onset
of programmed cell death, blockade of either NT-3 or trkC
also induced a significant reduction in cells in the DRG
suggesting that NT-3 regulates the activity of mitotically
active progenitor cells within the DRG (Gaese et al., 1994;
Lefcort et al., 1996). Targeted deletion of the NT-3 gene
results in the loss of up to 70% of the neurons in the DRG
in addition to a significant loss in non-neuronal cells within
the DRG (Ernfors et al., 1994; Farinas et al., 1994;
Tessarollo et al., 1994). Part of this loss has been attributed
to an alteration in the behavior of mitotically active
progenitor cells, causing either their death or their premature
exit from the cell cycle (Elshamy and Ernfors, 1996; Farinas
et al., 1996). Paradoxically, exogenous application of NT-3
in ovo during the peak period of neurogenesis within the
DRG also results in a significant reduction in the number of
neurons and dividing cells within sensory ganglia (Ockel et
al., 1996). Further complicating an elucidation of NT-3′s
role during sensory neurogenesis is the fact that although it
is the primary ligand for TrkC, NT-3 can also bind to other
trk family members, including trkA and trkB, in addition to
the common neurotrophin receptor p75NTR (Bothwell,
1995; Chao and Hempstead, 1995; Farinas et al., 1998;
Patapoutian and Reichardt, 2001). Lastly, the gene encoding
trkC is alternatively spliced to generate both the canonical,
kinase containing receptor, in addition to a truncated
receptor which lacks the kinase domain, but instead
expresses a novel cytoplasmic tail that is highly evolution-
arily conserved (Lamballe et al., 1993; Tsoulfas et al., 1993;
Valenzuela et al., 1993; Garner and Large, 1994). Both
receptors are expressed in the immature DRG during the
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the activity of cells within the DRG and their progenitors in
the neural crest (Tessarollo et al., 1997; Hapner et al., 1998;
Menn et al., 1998, 2000a,b; Palko et al., 1999; Rifkin et al.,
2000).
Given this complexity, one of the major goals of our study
was to elucidate the role of NT-3 in the immature DRG.
Specifically, we sought to resolve several outstanding ques-
tions: does NT-3 directly or indirectly regulate progenitor cell
behavior; how can NT-3 both increase and decrease cell number
in the DRG; through which receptor (s) is NT-3′s early activity
mediated?
Here, we demonstrate that NT-3 and CNTF can regulate both
the proliferation of progenitor cells, including glial progenitors,
and neuronal differentiation within the immature DRG. These
divergent responses are dependent upon the concentration of
each factor, with lower concentrations inducing proliferation
and higher concentrations promoting neuronal differentiation.
We also provide evidence that both NT-3 and CNTF induce
proliferation of mitotically active DRG progenitor cells
indirectly, as a consequence of binding to and activating
nascent neurons thereby stimulating those neurons to release
mitogenic factors, including neuregulin, a known mitogen for
glial progenitors (Shah et al., 1994; Dong et al., 1995;Fig. 1. Dissociated DRG cultures support the genesis and differentiation of neuron
cultured an additional 18 h. Cells were then fixed and double labeled with antibodies t
of peripheral glial progenitor cells and glia; (B) Hu, a marker of neurons and a small s
Schwann cells; and (D) TrkC, a marker of neurons and a small subset of neural proLeimeroth et al., 2002). These data illustrate the existence of
reciprocal intercellular relationships among neurons, glia, and
mitotically active progenitor cells that ultimately act in concert




DRG were dissected from St. 24/25 chick embryos (E4.5; Spafas, white
leghorn, pathogen-free; Hamburger and Hamilton, 1951) and dissociated by
incubation in 0.25% trypsin-EDTA (Gibco) for 7 min at 37°C followed by
trituration through fire-pulled glass pipettes. Dissociated cells were plated at a
density of 10,000 cells per ml on 8-well glass chamber slides (Nunc) coated with
poly-D-lysine 1:100 (Sigma) and laminin 20 μg/ml (Gibco) and cultured for 6 or
24 h at 37°C, 7% CO2, in basal medium consisting of F-12 (Gibco) with 0.4 mg/
ml BSA (Sigma), 200 μg/ml transferrin (Gibco), 100 ng/ml selenium (Gibco),
10 ng/ml triiodothyroxine (Sigma), 25 ng/ml thyroxin (Sigma), and Penstrep-
AmphB (Sigma). To assay mitogenic activity, 10 μg/ml BrdU was added to the
cultures at the time of plating along with the neurotrophins: NT3 (a gift from
Genentech Inc.), rat CNTF (R&D Systems), NGF (gift of Dr. Thomas Large) at
concentrations of 10 to 50 ng/ml.
Except for the experiments summarized in Figs. 1 and 2 and in Table 3, all
cultures were fixed 6 h after plating and processed for quantitative analysis.
Given the short 6 h culture period and that at this stage in ovo, neurogenesis is
just getting underway, it is not surprising that absolute numbers of neurons in thes and glia. Cultures were pulsed for the first 6 h with BrdU, washed, and then
o BrdU (red in panels A, B and D; yellow/green in panels C and A) 7B3, a marker
ubset of neural progenitor cells; (C) P0, a marker of Schwann cell precursors and
genitor cells. Asterisks indicate double labeled cells.
Fig. 2. Both NT-3 (10 ng/ml) and CNTF (10 ng/ml) significantly increase total
cell number, above what was originally plated, after 24 h in culture. Cells were
incubated in either NT-3, CNTF, NGF, TrkC IgG (10 μg/ml), control rabbit IgG
(10 μg/ml), or no added factor, in defined medium. About 1500 cells were plated
per well, and all cells per well were counted 3 h after plating, and again 24 h after
plating. The % change in cell number between those two time points is
indicated. All treatments per experiment were conducted in quadruplicate. The
results are expressed as the mean ± SEM; n = 5 experiments. Statistical
significance determined by ANOVA and Student–Newman–Keuls, P≤ 0.0001;
* indicates P ≤ 0.05.
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obtaining confounding trophic effects of growth factors independent from their
mitogenic effects. Similarly, numbers of mitotically active cells are also low
because of the short culture period. In spite of these low absolute numbers,
neurotrophic factor-induced changes were consistently statistically significant
(see below).
Immunocytochemistry
Cultured cells were fixed with 4% paraformaldehyde in phosphate buffer,
pH 7.4, for 30 min at room temperature. Cells were rinsed in F-12 and TBS
(25 mM Tris, 150 mM NaCl, pH 7.4), culture chambers were removed, and
slides were pretreated with 2 N HCl for 15 min at room temperature and with
exonuclease 2.5 μl/ml (Promega) and DNAse μl/ml (Promega) for 15 min at
37°C. After pretreatment, the slides were rinsed in blocking buffer (normal goat
serum 10%, glycine 1%, Triton-X 100 0.2% in TBS) four times for 10 min
followed by incubation in primary antibody(ies) overnight at 4°C. The primary
antibodies were diluted in blocking buffer as follows: rat anti-BrdU (Serotec,
1:1000), rabbit anti-neurofilament (1:300, Chemicon), mouse anti-P0 1:20
(Developmental Hybridoma Bank), rabbit anti-7B3 1:10,000 (gift of Dr. Paul
Henion, Ohio State University), mouse anti-Hu 1:200 (MAb 16A11, which
recognizes all chick Hu proteins, gift of Dr. Paul Henion, and Dr. Jim Weston,
University of Oregon), and rabbit anti-trk C (CTC IgG; 1 μg/ml; Lefcort et al.,
1996). Neuregulin staining was performed on 20 μm cryosections from staged
chick embryos fixed in 4% paraformaldehyde in PBS for 1 or more hours at
room temperature using 1310 antibodies to the proNRG precursor cytoplasmic
tail together with the monoclonal antibody 4D5 against islet-1/2 as described
previously (Loeb et al., 1999).
The following day, slides were rinsed with blocking buffer and incubated in
either biotinylated secondary antibody followed by 1 h incubation in an avidin-
fluorophor conjugate or fluorophore-conjugated secondary antibody(s) for 1 h atroom temperature. DAPI 0.3 μg/ml (4′, 6-diamidino-2-phenylindole dihy-
drochloride, Molecular Probes) was included in the secondary staining step to
facilitate counting total cell number. Slides were mounted in Prolong Antifade
(Molecular Probes) and examined on a Nikon FXA microscope.
Quantification of mitosis and differentiation
Toquantifymitosisanddifferentiation in6hcultures,astandardgridwasdesigned
such that500cells (DAPI+)werecounted in10designated fields that representedeach
regionofthecoverslip.Inaddition,allBrdUpositiveand/orneurofilamentpositivecells
were countedwithin each field. For each experiment, 4wells were counted, and each
experiment was repeated at least 3 times.We noticed that the cell plating density was
critical for consistent results to be obtained, hence responses were somewhat variable
between experiments, although each experiment yielded the same statistically
significant results. Thus, in order to combine results across experiments, absolute cell
numbers were converted to percentages. One-wayANOVA statistical analysis on the
cell countswascarriedoutoneachexperiment, followedbyStudent–Newman–Keuls
analysis.
To determine the identity of the progenitor cells that were stimulated to enter
the cell cycle by NT-3 or CNTF, BrdU was included in the media for 6 h culture
period. Cells were then fixed and labeled with antibodies to progenitor cell
markers to identify the class of progenitor cell stimulated to divide in addition to
antibodies to BrdU. We could identify four different classes: P0+ Schwann cell
progenitors (Bhattacharyya et al., 1991), 7B3+ glial progenitors (Henion et al.,
2000), Hu+ neural progenitors (Marusich et al., 1994), and TrkC+ neural
progenitors (Rifkin et al., 2000). An additional strategy for identifying the
progenitors stimulated to proliferate was to pulse the cultures for 6 h with NT-3
or CNTF and Brdu, then wash out the media and replace it with media lacking
added growth factors or BrdU and culture the cells for an additional 18 h. Thus,
any daughter cells generated in culture would be BrdU+, and their identity could
be determined with glial or neural markers. Cells were then fixed and labeled
with cell marker specific antibodies and antibodies to Brdu. To determine the
function of TrkC and p75NTR in the NT-3-induced responses, cells were
cultured in antibodies that are known to block each receptor, respectively: CTC
IgG (Lefcort et al., 1996) and CHEX (Weskamp and Reichardt, 1991; kind gift
of Dr. Louis F. Reichardt).
Neuregulin measurement and blockade
Supernatants removed from 6 h DRG cultures were assayed for neuregulin
concentration as previously described (Esper and Loeb, 2004). Briefly, samples
were concentrated 10-fold using the Centricon-10 device (Millipore) to 50 μl
and reconstituted in 100 μl of L6 cell culture media. The samples were then
exposed to differentiated L6 myotubes for 45 min to allow neuregulin activation
of the erbB receptors. The cells were lysed and ErbB2 and ErbB3 were
immunoprecipitated. The proteins were resolved by 5% SDS-PAGE and
transferred to a PVDF membrane, and probed with a phosphotyrosine antibody
(4G10, Upstate). The membrane was then stripped and reprobed with the ErbB
antibodies to measure total protein. Samples were compared to known standards
for quantification. The ratio of tyrosine-phosphorylated ErbB protein to total
ErbB protein is a quantitative and linear measurement of neuregulin
concentration. Blockade of neuregulin signaling was achieved using the NRG
antagonist, IgB4, a fusion protein between the extracellular domain of erbB4 and
human IgG (Chen et al., 1996; Esper and Loeb, 2004).Results
NT-3 and CNTF each induce proliferation of immature DRG
progenitor cells
Our goal in this study was to identify factors that regulate the
genesis and differentiation of cells within the developing dorsal
root ganglion. To approximate the environment in situ, thereby
maintaining potential community effects (Sextier-Sainte-Claire
Deville et al., 1992; Gurdon et al., 1993; Sommer, 2001), we
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relatively high density, rather than isolating cells in clonal culture.
The peak in neurogenesis in the chick DRG is ca. Embryonic
Day (E) 4.5 (Carr and Simpson, 1978); hence we studied the
effects of growth factors on dissociated cell cultures derived
from E4.5/St.24–25 DRG. We first sought to determine whether
our culture conditions would support the genesis and differen-
tiation of neurons and glia given that previous studies had
observed a lack of neurogenesis within dissociated DRG
cultures (Ernsberger and Rohrer, 1988). To this end, we pulsed
dissociated cultures of E4.5 DRG for 6 h with the thymidine
analogue, BrdU, cultured cells for an additional 18 h and
characterized the BrdU-labeled progeny. Using several neural
and glial markers, we found that both BrdU+ neurons and glia
were generated and differentiated in culture (Fig. 1). By 48 h,Fig. 3. Both NT-3 (10 ng/ml) and CNTF (10 ng/ml) significantly increase the number
trkC IgG, control rabbit IgG, or no treatment for 6 h in defined medium, in the prese
number of BrdU+ cells determined in experimental and control wells. For each experim
is depicted for quadruplicate wells; (A) CNTF and NT-3 each increase cell proliferati
as effective as NT-3 in stimulating BrdU uptake; n = 3; P ≤ 0.001; (C) TrkC Fabs or
data demonstrate that BrdU uptake is completely inhibited by blockade of TrkC; n = 2;
per experiment for each treatment. n = 4 separate experiments; P ≤ 0.001. TrkC Fa
indicates P ≤ 0.05.16% of BrdU+ cells was immunopositive with neurofilament
antibodies (data not shown).
We next tested the ability of several candidate factors to
modify the activity of DRG progenitor cells. The factors we
tested, NGF, NT-3, and CNTF, are each themselves and/or
their receptors, expressed, within the nascent chick DRG
(trkA, trkB, trkC, p75NTR, CNTFrα/GPARα NT-3, NGF;
Pinco et al., 1993; Heuer et al., 1990; Heller et al., 1995; Von
Holst et al., 1997; Rifkin et al., 2000). In fact, both CNTFrα/
GPARα and trkC are among the earliest known neuronal
markers in the immature chick DRG and their early
expression patterns in the DRG appear virtually identical
(Von Holst et al., 1997; Rifkin et al., 2000).
DRG were dissociated and all cells per well were counted
both 3 h after plating and after 24 h in culture in order toof S-phase cells in 6 h cultures. Cells were cultured for 6 h in either NT-3, CNTF,
nce of BrdU. Cells were then fixed and labeled with antibodies to BrdU and the
ent, 500 cells were counted per well. The %mean difference, relative to control,
on and their effects are not additive, n = 5; P ≤ 0.002; (B) activating TrkC IgG is
control IgG Fabs (150 μg/ml) were added to some wells during the 6 h pulse and
(D) Brdu uptake is dependent upon NT-3 concentration; four wells were counted
bs did not alter ongoing BrdU uptake levels in control wells, data not shown. *
Fig. 4. CNTF exerts dose-dependent, pleiotropic effects on DRG cells. (A) At
lower concentrations, it induces proliferation while simultaneously retarding
neuronal maturation (B) as shown with two neuronal markers, neurofilament
and Tuj-1), while at higher concentrations CNTF increases neuronal
differentiation and decreases cellular proliferation. DRG were dissociated and
cells cultured for 6 h prior to fixation and labeling with antibodies to BrdU,
neurofilament, and/or Tuj-1. Values represent mean ± SEM, with 500 cells
counted per well for quadruplicate wells for 3 experiments; (B) P ≤ 0.002.
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factor. NT-3 or CNTF application (at 10 ng/ml) consistently
resulted in a greater number of cells per well at 24 h above what
was originally plated, indicating that these factors promote the
proliferation and/or survival of DRG progenitor cells (Fig. 2).
The positive effects of NT-3 could be mimicked by incubation
in bivalent antibodies to the extracellular domain of trkC (CTC
IgG), in lieu of neurotrophins, demonstrating that activation of
trkC alone is sufficient to induce the proliferation and/or
survival of mitotically active cells (Fig. 2). In contrast, NGF
application did not increase cell number in this paradigm, but
did prevent the loss of cells observed in the controls (Fig. 2).
The increase in cell number above what was originally plated
could be due to trophic and/or mitogenic effects of these factors
on mitotically active cells in these immature DRG (Lu et al.,
1996). Several studies have found that mitotically active
progenitor cells can depend on growth factors for survival
thus confounding the identification of factors that are truly
mitogenic. To distinguish between these possibilities, we
directly tested whether NT-3 or CNTF induced an increase in
BrdU uptake in a culture assay short enough such that no
significant apoptosis occurred, thereby obviating any potential
trophic affects of these factors. As Lu et al. (1996) found for
sympathetic neuroblasts, we found that in a short 6 h culture of
cells from dissociated E4.5 DRG, apoptosis was essentially
non-existent: 0.1–0.3% of the cells were TUNEL positive in the
absence or presence of neurotrophins (data not shown). Thus, in
this 6 h assay, any significant increase in cell number can be
attributed to mitogenesis; potential trophic effects of these
factors can be excluded. In control cultures, after 6 h, between
10 and 15% of the cells typically incorporate BrdU (e.g. see Fig.
3D). As shown in Fig. 3A, both NT-3 and CNTF increased
BrdU uptake significantly: the addition of each at 10 ng/ml
resulted in a 25–50% increase, depending upon the experiment
(P ≤ 0.0001, e.g. Figs. 3B, C), in the number of BrdU+ cells
after 6 h in culture, relative to control. No additive or synergistic
effects were observed when CNTF and NT-3 were combined
suggesting that they are both acting on the same cell population.
The effect of NT-3 on BrdU uptake could be completely
mimicked by substitution of the activating trkC IgG in lieu of
NT-3, indicating that activation of trkC is sufficient for
induction of cell proliferation (Fig. 3B). Confirmation of the
role of trkC in the NT-3-induced proliferation response was
derived from our finding that blocking antibodies to trkC
abrogated the NT-3-induced proliferation (Fig. 3C). Thus, trkC
activation is both necessary and sufficient for DRG progenitor
cell mitogenesis. Our data also show that the response to NT-3
was biphasic: concentrations below 25 ng/ml caused a
significant increase in BrdU+ uptake relative to control;
however, concentrations greater than 25 ng/ml resulted in a
significant decrease in the number of BrdU+ cells (Fig. 3D).
The same pattern of dose-dependent response to CNTF was
identified: lower concentrations induced BrdU incorporation
while at higher CNTF concentrations (>25 ng/ml), BrdU
incorporation was significantly reduced (Fig. 4A). Thus, not
only do these data demonstrate that NT-3 and CNTF can
regulate mitogenic activity in DRG, but also that these factorscan both increase and decrease ongoing cellular proliferation
depending upon their concentration.
NT-3 and CNTF also promote the differentiation of nascent
DRG neurons
These data reveal a mitogenic role for NT-3 and CNTF on
DRG progenitor cells. Yet given that the peak period of
proliferation within the DRG overlaps temporally with the first
wave of neuronal differentiation, we asked whether NT-3 and
CNTF might also influence neuronal differentiation at this
stage (Pannese, 1974; Carr and Simpson, 1978). To examine
this question, we quantified the number of neurons present
after the 6 h culture in NT-3 or CNTF. A cell was counted as a
neuron if it was neurofilament+ or Tuj-1+ and had an axon of
at least one cell diameter. Total neuronal numbers were low
due to the short 6 h culture period. Figs. 4A and 5A
Fig. 5. NT-3-induced neuronal differentiation is dose-dependent and is mediated by TrkC. (A) Cells were cultured for 6 h in the presence of different concentrations of
NT-3. After 6 h, cultures were fixed and stained with antibodies to neurofilament (NF) and the percentage of NF+ cells determined in 500 cells per well, quadruplicate
wells for 3 separate experiments. Asterisks indicate significant increases (P ≤ 0.05) as determined by ANOVA and Student–Newman–Keuls analysis. (B) Incubation
in an antibody to the extracellular domain of trkC (CTC Fabs) blocks the NT-3-induced increase in neuronal differentiation. Cells were cultured for 6 h in the presence
or absence of trkC antibodies (CTC Fabs, 150 μg/ml) or control rabbit antibodies (150 μg/ml) plus or minus NT-3 (10 or 50 ng/ml). At 6 h, cultures were fixed and
stained with antibodies to NF (as above) and the percentage of neurofilament cells determined per well. As in panel A, 500 cells were counted per well, each
experiment was conducted in quadruplicate and each experiment repeated 3 times. Data demonstrate that incubation with antibodies to TrkC completely blocks the NT-
3-induced increase in neural differentiation, indicating that the NT-3-induced neural differentiation is dependent upon activation of TrkC. (C) Blocking antibodies to
p75NTR (CHEX, 500 μg/ml) do not abrogate the NT-3-induced neural differentiation. Cells cultured as above in the presence or absence of blocking antibodies to p75
or control antibodies, and at 6 h, cells were fixed and stained with an antibody to neural specific b-tubulin, Tuj-1. The percentage of Tuj-1+ cells in 500 cells/well,
quadruplicate wells, from 3 separate experiments was determined. For panels A, B, and C, asterisks indicate significant increases (P≤ 0.05) as determined by ANOVA
and Student–Newman–Keuls analysis.
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NT-3 and CNTF cause a significant increase in neuronal
number. When the two factors are directly compared, as
summarized in Table 1, they can each nearly double the
number of neurons that differentiate in 6 h cultures. One
difference between the two factors is that the same concentra-
tion of CNTF that induced maximal cell proliferation (10 ng/ml) simultaneously caused a significant decrease in the number
of neurons with axons during this 6 h period (Fig. 4B; as
defined by two markers, neurofilament expression and tuj-1+
immunoreactivity). Thus, while at higher concentrations
(>25 ng/ml) CNTF promotes neuronal differentiation, at
lower concentrations it retards neuronal maturation as defined
by axonal outgrowth.
Table 1
High concentrations of NT-3 and CNTF increase neuronal maturation, as
defined by inducing a significant increase in neurons with axons, in 6 h cultures
Treatment NF+ cell body only NF+ cells with axons
control 4.3 ± 1.1 44 ± 2.7
NT-3 (10 ng/ml) 2.3 ± 0.6 47 ± 3
NT-3 (50 ng/ml) 3.8 ± 1.1 75 ± 2.5*
CNTF (35 ng/ml) 2.8 ± 0.5 79 ± 1.3*
500 cells were counted per well, with quadruplicate wells for each of three
separate experiments. The number of neurofilament+ cells with or without axons
was determined for each well. Table depicts the mean number of cells in each
category ± SEM. NT-3 (50 ng/ml) and CNTF (35 ng/m) induced a significant
increase in the number of NF+ cells with axons (ANOVA, P ≤ 0.0001). Total
neuronal numbers are low due to the short, 6 h, culture period and immaturity of
DRG at time of dissection (see Methods).
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was mediated through activation of trkC, we tested whether
blocking antibodies to trkC (Lefcort et al., 1996) would block
the response (Fig. 5B). We found that the NT-3-stimulated
neural differentiation response was completely abrogated in the
presence of the blocking trkC Fabs. Incubation in the presence
of blocking antibodies to p75NTR did not interfere with the NT-
3 induced-neural differentiation (Fig. 5C).
Concentrations of either ligand that caused the most
significant increase in neuronal differentiation (>25 ng/ml) are
also those that induced the greatest decrease in cell proliferation
in the same 6 h assay (compare Fig. 3D to Figs. 4A and 5A).
Thus, NT-3 and CNTF are pleiotropic in that they can stimulate
both cellular proliferation and neuronal differentiation, with the
selection of biological response determined by ligand concen-
tration. Examination of the dose response curves for both
factors reveals an inverse relationship between proliferation and
differentiation; that is, concentrations that induce proliferation
typically are those at which neuronal differentiation is either
unaffected (NT-3) or inhibited (CNTF), while concentrations
that stimulate neuronal differentiation inhibit cellular
proliferation.
NT-3 and CNTF induce the proliferation of glial progenitor
cells
To identify the cellular targets induced to proliferate by NT-3
and CNTF, we sought to characterize (1) the identity of the
progenitor cells stimulated into S-phase during the 6 h
incubation with neurotrophic factors and (2) the identity ofTable 2
NT-3 and CNTF stimulate the proliferation of glial progenitor cells
Marker Control (%) + NT-3 (%)
TrkC 2.3 ± 0.9 1.0 ± 0.4 P ≤ 0.
Hu 1.6 ± 0.9 1.5 ± 0.6 P ≤ 0.
7B3 17.5 ± 1.8 22.5 ± 1.3 P ≤ 0.
P0 7.5 ± 0.7 11.5 ± 1.0 P ≤ 0.
To determine the identity of the mitotically active progenitor cells stimulated to enter
culture period with BrdU, and then fixed and double labeled with one of the progenito
were counted per well and the percentage of BrdU+/marker+ cells determined for ea
mean ± SEM from 3 experiments, quadruplicate wells. P values determined by ANthe descendants of those progenitor cells that were stimulated to
enter the cell cycle. With the markers available to us, we could
identify the Hu+ neural progenitors (which may overlap with a
small subpopulation of trkC+ progenitors we have identified in
vivo; Rifkin et al., 2000), and two classes of glial progenitors:
P0+ progenitors, which are Schwann cell progenitors and 7B3+
progenitors, which are more multipotent in terms of the classes
of glial cells they give rise to (Bhattacharyya et al., 1991;
Henion et al., 2000). As defined by BrdU labeling and
summarized in Table 2, NT-3 (10 ng/ml) significantly induced
the P0+ progenitor cells to enter the cell cycle (P ≤ 0.02) while
also stimulating 7B3+ progenitor cells. Similarly, CNTF (10 ng/
ml) caused a significant increase in the number of both 7B3+
and P0+ cells in S-phase during the 6 h pulse. During this 6 h
pulse with either NT-3 or CNTF, there was no increase in the
number of Hu+ or TrkC+ neural progenitor cells. This suggests
that glial progenitors are stimulated to proliferate in the presence
of NT-3 or CNTF. The majority of the remaining dividing
progenitor cells not immunopositive for our markers most likely
belong to the notch+ class of progenitor cells which have been
shown to comprise the majority of dividing cells at this stage in
the DRG (Wakamatsu et al., 2000; Hagedorn et al., 1999, 2000;
Nelson and Lefcort, unpublished observations). The cell cycle is
ca. 8–12 h at this stage for glial and neural progenitors (Lefcort
and Todd, unpublished), hence this approach provides a means
of directly identifying the progenitors that were stimulated to
divide by added factor.
As another approach for identifying the classes of
progenitor cells stimulated to enter the cell cycle by NT-3
and CNTF, we sought to characterize their descendants. To this
end, we incubated cultures for 6 h in BrdU and either NT-3 or
CNTF or no treatment, washed the wells removing the BrdU
and growth factors, and then continued to culture the cells for
an additional 18 h in a cocktail of growth factors in an attempt
to maximize cell survival. Thus, the only difference between
the wells would be the initial 6 h period in which cells would
have been exposed to either NT-3 or CNTF or no growth
factor. The descendants of the cells that were stimulated to
enter the cell cycle during the 6 h pulse with NT-3 or CNTF,
would be identifiable with BrdU immunocytochemistry, and
their identity could be determined using glial and neural
markers. Under these conditions, about 25–30% of the cells in
the cultures were BrdU+. Table 3 summarizes the results of
these experiments and demonstrates that both CNTF and NT-3
led to a significant increase in the number of glial cells, bothControl + CNTF
2 0.6 ± 0.2 0.9 ± 0.3 P ≤ 0.55
9 1.5 ± 0.7 1.3 ± 0.5 P ≤ 0.8
08 3.5 ± 0.5 6.5 ± 0.6 P ≤ 0.002*
02* 2.9 ± 0.2 7.4 ± 0.5 P ≤ 0.000*
the cell cycle by NT-3 and CNTF, cell cultures were incubated for the entire 6 h
r-specific antibodies listed, in addition to an anti-BrdU antibody. 500 BrdU+ cells
ch condition. Only one marker antibody was used per well. Values represent the
OVA and Student–Newman–Keuls.
Table 3
NT-3 and CNTF stimulate the genesis and differentiation of glial cells
Marker Control NT-3 (10 ng/ml)
NF 0.5% ± 0.2 0.25% ± 0.15 P ≤ 0.36
Hu 1.5% ± 0.4 0.63% ± 0.2 P ≤ 0.1
P0 7.25% ± 0.5 10.7% ± 0.65 P ≤ 0.006*
7B3 5.2% ± 0.6% 9.7% ± 0.6 P ≤ 0.002*
Marker Control CNTF (10 ng/ml)
NF 1.6% + 0.7 2.6% + 0.5 P ≤ 0.3
TrkC 1% + 0.3 1.4% + 0.3 P ≤ 0.4
P0 3% + 0.7 9.4% + 0.5 P ≤ 0.0001*
7B3 8.5% + 0.35 10.8% + 0.6 P ≤ 0.017*
As a second approach to identifying the classes of progenitor cells stimulated to
enter the cell cycle by NT-3 and CNTF, BrdU and either NT-3 (10 ng/ml) or
CNTF (10 ng/ml) were added to the media for the first 6 h of cell culture. Media
were then washed extensively, and replaced with media that lacked any BrdU or
NT-3 or CNTF and the cells were cultured for an additional 18 h. Cells were then
fixed and labeled with antibodies to BrdU (to identify daughters of cells
stimulated to divide in the first 6 h) and one of the cell specific marker
antibodies. Approximately 20% of the cells were BrdU+ after this culture
period. Depicted values represent the percent of BrdU+ cells that express each of
the markers; 200 BrdU+ cells counted per well, quadruplicate wells for 3–5
separate experiments. Analysis of data by ANOVA followed by Student–
Newman–Keuls. Only one marker antibody was used/well.
Fig. 6. Following just a 6 h pulse of CNTF or NT-3, both the number of neurons
and glia is increased by 24 h. Cells were cultured for 6 h in the presence or
absence of neurotrophic factor, followed by several rinses, and then all wells
cultured for an additional 18 h in the same defined medium. Cells were then
fixed and labeled with antibodies to PO and neurofilament and the percentage of
neurons and Schwann cells determined out of a total count of 500 cells per well.
Values represent the mean ± SEM from quadruplicate wells from 2 different
experiments; P ≤ 0.001 for both P0 and NF.
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glial marker, it will label both Schwann cells and satellite glia,
in addition to glial progenitors, thus there is some overlap in
the P0+ and 7B3+ subpopulations (Henion et al., 2000). No
significant increase in the number of BrdU+ neurons was
observed. However, when the total number of neurons (Brdu+
and Brdu−) was determined in these 24 h cultures following
the initial 6 h pulse of neurotrophic factors, an increase in both
neuronal and glial numbers were measured (Fig. 6). Thus,
generation of more glia leads to an increase in neurons, most
likely by providing trophic support in agreement with several
other published studies (Sonnenberg-Riethmacher et al., 2001;
Britsch et al., 2001; Chen et al., 2003).
Do NT-3 and CNTF exert their mitogenic effects directly
or indirectly? Our data indicate that trkC is required for the
NT-3-induced response and in vivo we and others have
clearly shown that trkC is only expressed on neurons and a
subpopulation of neural progenitors in the immature DRG at
this age, and is not expressed by glial cells nor glial
progenitors (Henion et al., 1995; Farinas et al., 1998; Rifkin
et al., 2000). However, given that in vitro, molecular
expression patterns can be misregulated, it was possible
that trkC was misexpressed on non-neural progenitor cells in our
cultures. To test this, we determined the identity of trkC+ cells by
double labeling with the neuronal marker Hu, and/or with
the glial marker P0. We determined that 96 ± 0.8% of trkC+
cells also co-expressed Hu (153/160 total cells counted)
while none of the TrkC+ cells co-expressed the glial marker
P0 (0/157 total cells counted). Similar data have been
obtained for co-expression of the CNTF receptor, CNTFrα
by Von Holst et al. (1997) where in cultures of E5 DRG
cells, CNTFrα expression was restricted to sensory neurons
and neural precursor cells. Thus, our data support a modelin which NT-3 and CNTF induce mitogenesis indirectly, by
first binding to neurons and stimulating the release of a
mitogen.
NT-3 and CNTF-induced secretion of neuregulin stimulates
proliferation of DRG progenitor cells
We next sought to identify the mitogen released by
neurons in response to neurotrophin stimulation. Neuregulins
are known to be secreted by neurons and to induce the
proliferation and differentiation of Schwann cell precursors
and Schwann cells (Dong et al., 1995; reviewed in Jessen and
Mirsky, 1999; Garratt et al., 2000; Leimeroth et al., 2002).
Furthermore, neurotrophins have been shown to rapidly
upregulate the transcription of neuregulins in embryonic
motor neurons at the time when axons first contact muscle in
vivo (Loeb and Fischbach, 1997) and the secretion of
neuregulin from motor neurons and E12 DRG neurons
(Esper and Loeb, 2004). We first checked by immunohisto-
chemistry whether neuregulin was expressed in the immature
DRG (Fig. 7) and found that it was strongly expressed during
the peak period of neurogenesis and differentiation in the
Fig. 7. Neuregulin is strongly expressed in the immature DRG, as early as E3.
Cryosections of E3 and E5 embryos were immunolabeled with antibodies to
Islet 1/2 to label nascent sensory neurons (red) and neuregulin (green). Note that
neuregulin expression corresponds with the neural core region of the ganglion.
nt = neural tube; arrow points to DRG.
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of nascent postmitotic neurons that also express the
transcription factor islet-1 (as opposed to the perimeter
which is comprised of mitotically active progenitor cells at
this age; E5). Given that gliogenesis is only in its infancy at
E5, and the fact that neuregulin is co-localized with Islet-1,
the most likely interpretation is that neuregulin is synthesized
by neurons in the immature DRG. The neuregulin receptor
ErbB3 has been shown to be expressed by cells that compose
the perimeter of the nascent DRG in the mouse (Riethmacher
et al., 1997), consistent with its expression on DRG
progenitor cells.
We next sought to determine whether in our cultures, NT-3
and CNTF were inducing the secretion of neuregulin. To this
end, supernatants removed from 6 h DRG cultures were
concentrated and the amount of neuregulin activity was
measured using a biological assay that quantifies the extent of
neuregulin receptor tyrosine phosphorylation in L6 muscle
cells (Loeb and Fischbach, 1997; Esper and Loeb, 2004).
After a 45 min exposure to the DRG supernatants, lysates
were prepared, ErbB receptors were immunoprecipitated, and
probed for phosphotyrosine on Western blots. We found thatboth NT-3 and CNTF induced a dose-dependent increase in
neuregulin secretion (Fig. 8) raising the possibility that the
proliferative response induced by NT-3 and CNTF was
mediated by neuregulin. To test this, cell cultures were
incubated for 6 h in the presence of NT-3 or CNTF with and
without the neuregulin antagonist IgB4. Results summarized
in Fig. 9 demonstrate that blocking neuregulin activity
eliminated the CNTF-induced cell proliferation and also
reduced about half of the NT-3 induced proliferation. In
addition, we found that the neuregulin antagonist reduced
some of the proliferation in control wells, suggesting ongoing
release of endogenous neuregulin in DRG cultures that can be
upregulated by CNTF and NT-3. This is the first demonstra-
tion of the regulation of neuregulin secretion by CNTF and
the first evidence for NT-3 and CNTF-induced non-neuronal
cell proliferation, indirectly, by stimulating neurons to release
neuregulin. The fact that the neuregulin antagonist did not
block all of the NT-3-induced proliferation would suggest the
presence of an additional mitogen that is secreted by neurons
following NT-3 stimulation.
Since higher concentration of neurotrophins decrease
proliferation in 6 h cultures, neuregulin secretion might
have been predicted to decrease at higher neurotrophin
concentrations. In fact, the release of neuregulin did not
decrease with higher concentrations of NT-3 or CNTF (Fig.
8). Thus, maximal neuregulin secretion was achieved at those
concentrations of CNTF and NT-3 that actually inhibit
cellular proliferation in our cultures. This could suggest that
the neuregulin-induced proliferation is dose-dependent, with
higher neuregulin concentrations actually inhibiting or retard-
ing proliferation. However, such inhibition would be
temporary, as proliferation rebounds during the subsequent
24 h (data not shown). Alternatively, an additional factor
might be released in response to higher neurotrophin
concentrations that interferes with neuregulin, preventing it
from stimulating mitogenesis. Since most of the known
soluble forms of neuregulin-1 bind to and are regulated by
heparin sulfate proteoglycans in the extracellular matrix (Li
and Loeb, 2001), it is possible that increasing neurotrophin
concentrations alter the activity of these neuregulin modula-
tors thereby underlying the reduction in mitogenesis at high
neurotrophin concentrations.
Proliferating cells are often adjacent to neurons
Our data point to an integral relationship between neurons,
glia, and mitotically active progenitor cells in the DRG.
Interestingly, when scanning our cultures, we often observed
dividing cells directly adjacent to postmitotic neurons (Fig. 10).
In fact, occasionally dividing cells were actually circumscribed
entirely by axons (Fig. 10). Intercellular junctions between
mitotically active DRG progenitor cells and differentiated
neurons have been described at the level of electron microscopy
by Pannese (1974). Thus, considered together, our data would
support a model in which growth factors such as NT-3 and
CNTF at low concentrations, bind to immature neurons and
promote the release of mitogen(s), including neuregulin, from
Fig. 9. Blockade of neuregulin binding completely prevents CNTF-induced
proliferation and reduces NT-3-induced proliferation by about 50%. All
experiments were conducted in quadruplicate, n = 3 experiments; P ≤ 0.001.
Fig. 8. NT-3 and CNTF stimulate secretion of neuregulin in a dose-dependent manner. Cells were cultured for 6 h as described. Supernatants were collected,
concentrated, and incubated with L6 cells that expressed ErbB receptors. L6 cells were then lysed, ErbB receptors immunoprecipitated, followed by SDS-PAGE, and
immunoblotting with an antibody to phosphotyrosine. The membrane was then stripped and reprobed with antibodies to erbB (A). Normalized data are depicted in
panel B. Data are shown for one experiment, although this experiment was conducted twice, with each demonstrating the same increases in neuregulin secretion.
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adjacent progenitor cells, including glial progenitors (Fig. 11).
This increase in glia, then leads ultimately to an increase in
neurons, most likely by providing trophic support (e.g. Fig. 6).
However, higher concentrations of these same factors exert a
different biological response: CNTF and NT-3 temporarily
inhibit mitogenic activity, while simultaneously enhancing the
rate of neuronal differentiation of nascent neurons (Fig. 10).
These data suggest a model in which the local concentration of a
given growth factor, depending upon the cellular context, can
exert such distinct biological responses as proliferation or
cellular differentiation.
Discussion
NT-3 can regulate both DRG progenitor cell proliferation and
sensory neuronal differentiation
This study resolves several outstanding issues concerning
the role of NT-3 in the immature DRG. Studies in mice in which
the gene encoding NT-3 has been deleted indicate that the
behavior of mitotically active progenitor cells in the immature
DRG is altered: one study concluded that these cells die in the
absence of NT-3 while another determined that they prema-
turely exit the cell cycle (Farinas et al., 1996, 2002; Elshamy
Fig. 10. Mitotically active cells are often observed in direct contact with
neurons. Cells were cultured for 6 h and double labeled with antibodies to
neurofilament (red) and BrdU (green) or DAPI (blue). (A) The cell in S-phase
(green, BrdU) is juxtaposed to the neuronal cell body (red). (B) Here a neuron's
axon (red, labeled with neurofilament antibodies) has completely encircled a
dividing cell observed in telophase (blue, DAPI). Arrowhead points to a
dividing cell in contact with a neuron.
Fig. 11. Schematic summary of the pleiotropic effects of NT-3 and CNTF on
cells in the developing dorsal root ganglion. Varying concentrations of NT-3 and
CNTF exert distinct biological activities on cells in the immature DRG with low
concentrations inducing cell proliferation, indirectly, while high concentrations
promote neuronal differentiation.
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elucidation of the intercellular mechanisms mediating the
response was incomplete; the data presented here help clarify
how the absence of the NT-3 could lead to the described deficits.
Our data demonstrate that NT-3 promotes the proliferation of a
subset of DRG progenitor cells, and that this response requires
neuron-expressed trkC, and that this NT-3 activation stimulates
these neurons to release mitogen(s), including neuregulin, that
then induce the proliferation of neighboring progenitor cells.
This would also support a conclusion drawn in the NT-3 knock
out studies in which it was hypothesized that the premature exit
of progenitor cells from the cell cycle was the indirect result of
the death of NT-3-dependent postmitotic neurons (Farinas et al.,
1998, 2002). Our data support the idea that one function of NT-3
is to indirectly maintain the proliferation of mitotically active
DRG progenitor cells. Furthermore, in the NT-3 knock out
mice, total cell number, above neuronal cell number, was
reduced in embryonic DRG, in addition to a decrease in the
number of proliferating cells, supporting our finding that NT-3
promotes (indirectly) the proliferation of DRG progenitor cells
(Elshamy and Ernfors, 1996; Farinas et al., 1996; Liebl et al.,
1997). With the death of postmitotic neurons due to the absence
of NT-3, neuronal-release of neuregulin would be diminishedthereby ultimately reducing cell number in the DRG due to a
decrease in progenitor cell proliferation.
Another intriguing observation in previous work concerning
the function of NT-3, was the finding that exogenously supplied
NT-3, between E3 and E6, actually decreased cellular
proliferation in sensory ganglia of chick embryos (Ockel et
al., 1996; F. Lefcort and V. Todd, unpublished observation).
This was perplexing in light of the NT-3 knock out mice
phenotype described above and studies in chick embryos
demonstrating that antibody blockade of NT-3 or its receptor
TrkC reduced cell number in the DRG (Gaese et al., 1994,
Lefcort et al., 1996). However, in our current study, we
demonstrate that high concentrations of NT-3 do in fact
decrease the proliferation of DRG progenitor cells. Thus, a
plausible explanation for the decreased proliferation observed in
embryos receiving exogenously supplied NT-3 is that the local
concentration of NT-3 was sufficiently high to reduce cellular
proliferation. As a consequence (either direct or indirect), due to
the decrease in progenitor cell proliferation, fewer neurons
would ultimately be generated or supported, thereby potentially
explaining the decrease in neuronal numbers observed at later
time points (E10–E11) in embryos infused early with
exogenous NT-3 (Ockel et al., 1996). Given our finding that
short exposures (i.e. 6 h) to high concentrations of NT-3 actually
increase neuronal differentiation while concomitantly decreas-
ing proliferation, it would have been interesting to determine
neuronal numbers after comparably short exposure periods to
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neuregulin, and Sox-10 knock out mice, it is apparent that the
final neuronal composition of the DRG is dependent upon
intercellular interactions with the non-neuronal members of the
DRG, that is, glial cells and mitotically active progenitor cells
(Farinas et al., 1996; Riethmacher et al., 1997; Sonnenberg-
Riethmacher et al., 2001), that could generate varying local
concentrations of NT-3 within the ganglion.
Verdi and Anderson (1994) have previously demonstrated a
dose-dependent divergent response to NT-3 in sympathetic
neuroblasts: low concentrations induced survival while higher
concentrations upregulated trkA expression and simultaneously
inhibited BrdU incorporation. Thus together, their study and
ours conclude that at higher concentrations NT-3 inhibits the
proliferation of progenitor cells in both sensory and sympathetic
ganglia while concomitantly promoting neuronal differentia-
tion. How can differing concentrations of the same ligand
induce such profoundly divergent responses? One plausible
mechanism proposes that the duration of MAPK activation
regulates down stream signaling pathways and determines
cellular response (Marshall, 1995; Schlessinger, 2000; Halfar et
al., 2001). NGF induces differentiation of PC12 cells along with
a sustained activation of MAPK whereas EGF induces PC12
cell proliferation and only a transient MAPK activation.
However, ectopic overexpression of EGF receptor induces a
sustained MAPK activation and subsequent neuronal differen-
tiation of PC12 cells (Qui and Green, 1992; Traverse et al.,
1994; Marshall, 1995). Similarly, ectopic overexpression of
EGF receptor biased cell fate differentiation in mammalian
retina (Lillien, 1995) and different threshold levels of EGF
signaling in Drosophila have been shown to regulate distinct
phenotypes in Drosophila retinal development (Lesokhin et al.,
1999). We have found a corresponding increase in the duration
of MAPK activation with increasing NT-3 concentrations (data
not shown) providing potential evidence for this pathway
mediating two distinct responses to the same ligand. Concen-
tration-induced differences in trkC internalization rates could
also explain the divergent biological responses (Sommerfeld et
al., 2000). Additional experimentation will be required to
elucidate the signaling mechanisms mediating the proliferation
vs. differentiation responses. Given that NT-3 is synthesized
within the DRG, it is interesting to consider the intercellular
mechanisms that could generate asymmetries or variations in
local concentration of NT-3 within the ganglion.
Another potential explanation for the dose-dependent
divergent responses to NT-3 might lie in the recruitment of a
distinct combination of trkC receptors. Immature DRG neurons
express both the full length, kinase containing trkC receptor and
the truncated trkC receptor that substitutes an evolutionarily
conserved cytoplasmic tail in lieu of the tyrosine kinase domain
(Tessarollo et al., 1997; Menn et al., 1998, 2000a,b; Rifkin et
al., 2000). It has been shown that targeted deletion of both trkC
isoforms results in a more severe depletion of sensory neurons
than does deletion of only the kinase-containing receptor
(Tessarollo et al., 1997; Liebl et al., 1997) suggesting that the
truncated receptor functionally contributes to DRG develop-
ment. Furthermore, while ectopic expression of the kinase-containing trkC isoform in neural crest cells induces both their
proliferation and neuronal differentiation, ectopic expression of
the truncated trkC receptor is incapable of inducing prolifera-
tion, but can significantly induce neuronal differentiation of
neural crest cells (Hapner et al., 1998). Thus, it is conceivable
that low concentrations of NT-3 are sufficient to activate the
kinase-containing trkC receptor, while at higher NT-3 concen-
trations, the truncated trkC receptor is recruited and stimulated,
thereby inducing neuronal differentiation. Further studies will
be required to directly identify the function of each receptor
subtype.
Cellular interactions regulating proliferation
Several pieces of evidence would indicate that the prolifer-
ative effects of CNTF and NT-3 must be indirect; that is, these
factors must first bind to receptors on neurons, and once
stimulated, these neurons then induce the proliferation of
neighboring progenitor cells. These data include: (1) direct
activation of trkC is necessary and sufficient to induce
proliferation of progenitor cells (Figs. 2 and 3B), indicating
that this response requires trkC. In vivo, we have previously
shown that at this age in the chick embryo, trkC expression is
restricted to neurons and a small population of mitotically active
cells only (Rifkin et al., 2000). However, our data in this current
study indicate that although these trkC+ progenitor cells are
present in the cultures, they are not those stimulated to divide by
NT-3 (Tables 2 and 3). Thus, although TrkC is required for
proliferation, it is not the TrkC+ cells that are stimulated to
proliferate. (2) In cultures of purified Schwann cell precursors
that were devoid of neurons, NT-3 had nomitogenic nor survival
activity (Jessen et al., 1994). (3) Pannese (1974) has shown by
electron microscopy the existence of adhesion plaques and gap
junctions betweenmitotic cells and adjacent resting cells (which,
at this early stage would be nascent neurons) in the immature
DRG. Interestingly, as the DRG matures, these intercellular
junctions disappear. We do find close physical juxtaposition of
neurons and mitotically active progenitor cells in our cultures,
although the cellular density in our cultures is sufficiently high to
also support the binding of a diffusible mitogen released from
neurons. (4) The early expression of CNTFRα/GPARα is
virtually identical to that of trkC in the immature DRG (E5; Von
Holst et al., 1997), that is, restricted to neurons and neural
progenitors and given that both factors induce the same amount
of proliferation of progenitor cells and their effects are not
additive, we suggest that CNTF exerts its actions via CNTFRα
on postmitotic neurons as does NT-3 via TrkC. Hence, since the
non-neuronal progenitor cells neither express trkC nor
CNTFRα, we propose that NT-3 and CNTF exert their
mitogenic effects on DRG progenitor cells indirectly, by first
binding to neurons thereby stimulating those neurons to release a
mitogen, including neuregulin, that subsequently induces
progenitor cell proliferation.
An extensive literature exists documenting the complex and
mutually dependent interactions among sensory neurons,
Schwann cell precursors, and Schwann cells. For example,
media conditioned by DRG neurons induced the survival of
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stimulate Schwann cell myelin protein synthesis (Jessen et
al., 1994; Pruginin-Bluger et al., 1997). Others and we have
shown the close juxtaposition between neurons and dividing
progenitor cells and previous studies have documented the
mitogenic effects of neurons on Schwann cells (Fig. 10; Wood
and Bunge, 1975; Salzer et al., 1980; Ratner et al., 1985;
Maurel and Salzer, 2000). Sox-10, a transcription factor
expressed by neural crest cells and their daughter glial
progenitor cells in the nascent DRG, when genetically deleted,
results in the absence of glial differentiation and indirectly, in
the death of sensory neurons in the DRG (Sonnenberg-
Riethmacher et al., 2001; Britsch et al., 2001). Targeted
deletion of the ErbB3 gene results directly in the loss of
Schwann cell precursors and Schwann cells which subse-
quently leads indirectly to the loss of 80% of the neurons
within the DRG (Riethmacher et al., 1997; Chen et al., 2003).
Neuregulin, an ErbB3 ligand, is a neuronally secreted
molecule that induces the survival and proliferation of
Schwann cell precursors and their conversion to mature
Schwann cells in addition to promoting the proliferation and
survival of perinatal Schwann cells (reviewed in Jessen and
Mirsky, 1999; Garratt et al., 2000; Woodhoo et al., 2004).
Loeb and Fischbach (1997) have shown that NT-3 can
upregulate neuregulin mRNA levels within 15 min in motor
neurons and induce the release of neuregulin from motor
neurons and mature (E 12) DRG neurons (Esper and Loeb,
2004). Here we extend those data by demonstrating that both
NT-3 and CNTF can also induce the release of neuregulin
from immature DRG cells. In another facet of these
intercellular inter-relationships, Verdi et al. (1996) have
shown that neuregulins released by sympathetic ganglia,
upregulate NT-3 mRNA synthesis by surrounding non-
neuronal cells while Hansen et al. (2001) found that nrg-b1
was reduced by NT-3 in spiral ganglia Schwann cells. The data
presented here reveal an additional feature of this interrela-
tionship by demonstrating that, at early stages in DRG
development, NT-3 and CNTF can induce the release of
neuregulin from nascent neurons, that subsequently promotes
proliferation of neighboring mitotically active DRG progenitor
cells. Cells that surround the DRG also synthesize NT-3
(Farinas et al., 1996) and hence a local source of NT-3 is
available to stimulate nascent DRG neurons to release
neuregulin. Our data further suggest that once threshold levels
of NT-3 are reached, cell proliferation is diminished in favor of
enhanced neuronal differentiation. Thus, a single factor, NT-3,
can regulate such pleiotropic events as cell survival,
proliferation, and differentiation during DRG development
by virtue of its local concentration and the intercellular
interactions between the diverse cell types that comprise the
developing DRG.
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